Erica F. Andersen

Erica F. Andersen, PhD, FACMG

Academic Information

Departments Primary - Pathology

Board Certification

  • American Board of Medical Genetics and Genomics (Laboratory Genetics and Genomics)
  • American Board of Medical Genetics (Clinical Cytogenetics)

Erica Andersen is an Associate Professor of Clinical Pathology at the University of Utah and is the Head of Clinical Operations for Cytogenetics and Molecular Genetics at ARUP Laboratories. She received a PhD in Genetics from the University of Wisconsin-Madison and completed a Clinical Cytogenetics fellowship at ARUP Laboratories and the University of Utah. Dr. Andersen is board certified in Clinical Cytogenetics and Laboratory Genetics and Genomics by the American Board of Medical Genetics and Genomics and is a fellow of the American College of Medical Genetics and Genomics. Her professional interests include improving diagnostics, interpretative tools, and laboratory standards for cytogenetic and genomic testing.

Education History

Undergraduate Macalester College
 BA
Doctoral Training University of Wisconsin-Madison
 PhD
Fellowship University of Utah and ARUP Laboratories
 Fellow

Selected Publications

Journal Article

  1. Ballout RA, Dickerson C, Wick MJ, Al-Sweel N, Openshaw AS, Srivastava S, Swanson L, Bramswig NC, Kuechler A, Hong B, Fleming LR, Curry KT, Robertson SP, Andersen EF, El-Hattab A (2020). Int22h1/Int22h2-mediated Xq28 duplication syndrome: de novo duplications, prenatal diagnoses, and additional phenotypic features. Human mutation, 41(7), 1238-1249.
  2. Riggs ER, Nelson T, Merz A, Ackley T, Bunke B, Collins CD, Collinson MN, Fan YS, Goodenberger ML, Golden DM, Haglund-Hazy L, Krgovic D, Lamb AN, Lewis Z, Li G, Liu Y, Meck J, Neufeld-Kaiser W, Runke CK, Sanmann JN, Stavropoulos DJ, Strong E, Su M, Tayeh MK, Kokalj Vokac N, Thorland EC, Andersen E, Martin C (2018). Copy number variant discrepancy resolution using the ClinGen dosage sensitivity map results in updated clinical interpretations in ClinVar. Human mutation, 39(11), 1650-1659.
  3. Thaxton C, Good ME, DiStefano MT, Luo X, Andersen EF, Thorland E, Berg J, Martin CL, Rehm HL, Riggs ER, ClinGen Gene Curation Working Group., ClinGen Dosage Sensitivity Working Group (2021). Utilizing ClinGen gene-disease validity and dosage sensitivity curations to inform variant classification. Human mutation, 43, 1031-1040.
  4. Zhou XA, Louissaint A Jr, Wenzel A, Yang J, Martinez-Escala ME, Moy AP, Morgan EA, Paxton CN, Hong B, Andersen EF, Guitart J, Behdad A, Cerroni L, Weinstock DM, Choi (2018). Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type. The Journal of investigative dermatology, 138(11), 2365-2376.
  5. Paxton CN, O'Malley DP, Bellizzi AM, Alkapalan D, Fedoriw Y, Hornick JL, Perkins SL, South ST, Andersen E (2017). Genetic evaluation of juvenile xanthogranuloma: genomic abnormalities are uncommon in solitary lesions, advanced cases may show more complexity. Modern pathology, 30(9), 1234-1240.
  6. Andersen EF, Paxton CN, O'Malley DP, Louissaint A Jr, Hornick JL, Griffin GK, Fedoriw Y, Kim YS, Weiss LM, Perkins SL, South S (2017). Genomic analysis of follicular dendritic cell sarcoma by molecular inversion probe array reveals tumor suppressor-driven biology. Modern pathology, 30(9), 1321-1334.
  7. Andersen EF, Carey JC, Earl DL, Corzo D, Suttie M, Hammond P, South S (2014). Deletions involving genes WHSC1 and LETM1 may be necessary, but are not sufficient to cause Wolf-Hirschhorn Syndrome. European journal of human genetics, 22(4), 464-70.
  8. Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, Raca G, Ritter DI, South ST, Thorland EC, Pineda-Alvarez D, Aradhya S, Martin C (2020). Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genetics in Medicine, 22(2), 245-257.
  9. Andersen EF, Baldwin EE, Ellingwood S, Smith R, Lamb A (2014). Xq28 duplication overlapping the int22h-1/int22h-2 region and including RAB39B and CLIC2 in a family with intellectual and developmental disability. American journal of medical genetics. Part A, 164A(7), 1795-801.
  10. Herriges JC, Brown S, Longhurst M, Ozmore J, Moeschler JB, Janze A, Meck J, South ST, Andersen E (2019). Identification of two 14q32 deletions involving DICER1 associated with the development of DICER1-related tumors. European journal of medical genetics, 62(1), 9-14.
  11. Zhou XA, Yang J, Ringbloom KG, Martinez-Escala ME, Stevenson KE, Wenzel AT, Fantini D, Martin HK, Moy AP, Morgan EA, Harkins S, Paxton CN, Hong B, Andersen EF, Guitart J, Weinstock DM, Cerroni L, Choi J, Louissaint (2021). Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features. Blood advances, 5(3), 649-661.
  12. Gonzales PR, Andersen EF, Brown TR, Horner VL, Horwitz J, Rehder CW, Rudy NL, Robin NH, Thorland EC, on behalf of the ACMG Laboratory Quality Assurance Committe (2022). Interpretation and reporting of large regions of homozygosity and suspected consanguinity/uniparental disomy, 2021 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG). Genetics in Medicine, 24(2), 255-261.
  13. Paulraj P, Bosworth M, Longhurst M, Hornbuckle C, Gotway G, Lamb AN, Andersen E (2019). A Novel Homozygous Deletion within the FRY Gene Associated with Nonsyndromic Developmental Delay. Cytogenetic and genome research, 159(1), 19-25.
  14. Wen T, Akay G, Palumbos J, Ostrander B, Quigley DI, Lamb AN, Andersen EF, Hong B, Viskochil (2025). Vertical inheritance and unique differential phenotypes of reciprocal recombinant chromosome 18 within a multi-generation family. European journal of human genetics,
  15. Attardi E, Gray N, Lewis S, Boals ME, Shaker P, Kotmayer L, Sahoo SS, Li P, Andersen EF, Zhao J, Pizzo L, Oved JH, Jesudas R, Reiss UM, Sharma R, Christakopoulos GE, Bhoopalan SV, Takemoto CM, Kennedy AL, Voso MT, Kang G, Wlodarski M (2025). Utility of Peripheral Blood Testing for Detection and Surveillance of Clonal Hematopoiesis in Predisposed Individuals (CH-IPI). Blood,

Review

  1. Pizzo L, Andersen EF, Best (2024). Detection of Germline Structural Variants Using Short-Read Whole-Genome Sequencing. Advances in Molecular Pathology, 7(1), 165-173.
  2. Lu X, Andersen EF, Banerjee R, Eno CC, Gonzales PR, Kumar S, Lager AM, Miron PM, Pugh T, Quintero-Rivera F, Thurston VC, Wolff DJ, Zhao J, Fonseca R, Baughn L (2025). Guidelines for the testing and reporting of cytogenetic results for risk stratification of multiple myeloma: a report of the Cancer Genomics Consortium Plasma Cell Neoplasm Working Group. Blood cancer journal, 15(1), 86.